Brenna Kelley Clarke
About Brenna Kelley Clarke
Brenna Kelley Clarke is the Director of Applied Virology at Bristol Myers Squibb in the Greater Seattle Area, with extensive experience in virology and bioanalytical methods.
Title
Brenna Kelley Clarke is a Director of Applied Virology at Bristol Myers Squibb, based in the Greater Seattle Area.
Current Role at Bristol Myers Squibb
Brenna Kelley Clarke holds the position of Director of Applied Virology at Bristol Myers Squibb. In this capacity, she launched viral vector analytics, formulations, and AAV process development teams, managing a multidisciplinary group of over 15 scientists. Additionally, she overhauled the analytics toolbox, leading the development and implementation of 23 new test methods. She also directed a team of 10 members to create a robust AAV manufacturing process suitable for the company's first-in-human gene-edited cell therapy. Clarke has played a key role in cultivating a positive team culture during the pandemic by organizing virtual scavenger hunts, delivering a mini-expert lecture series, and initiating a monthly department-wide lunch shuffle. Moreover, she spearheaded a strategic team to devise an end-to-end AAV analytics approach.
Previous Experience at Silverback Therapeutics
Before joining Bristol Myers Squibb, Brenna Kelley Clarke worked as the Director of Bioanalytical Methods at Silverback Therapeutics for 9 months from 2017 to 2018. During her tenure, she was responsible for leading bioanalytical strategies in the Greater Seattle Area.
Previous Experience at Immune Design
From 2010 to 2017, Brenna Kelley Clarke served as a Senior Scientist at Immune Design. Over her 7-year tenure, she was involved in senior-level scientific research, strengthening the company's virology and bioanalytical capabilities in the Greater Seattle Area.
Previous Experience at University of Washington
Brenna Kelley Clarke's journey in virology began as a Senior Fellow at the University of Washington, where she worked from 2006 to 2010. She contributed to various virology research projects for 4 years, gaining valuable expertise in her field.
Doctoral Studies at Harvard University
Brenna Kelley Clarke pursued her doctoral studies at Harvard University from 2001 to 2006, earning a Ph.D. in Virology and Medical Science. Her research during this period laid the foundation for her future career in applied virology.
Undergraduate Studies at University of Washington
Clarke completed her undergraduate education at the University of Washington from 1996 to 2000. She earned dual degrees, a BS in Biochemistry and a BA in Italian Language and Literature, providing her with a diverse academic background.